TNFSF10 and urinary bladder carcinoma: These results indicated that combined treatment significantly inhibited cell growth and enhanced TRAIL-induced apoptosis via activation of the caspase cascade in bladder cancer cells, but exhibited no sensitization effect on normal bladder epithelial cells.